ArticleComputers in biology and medicine2020
Development of a new fully three-dimensional methodology for tumours delineation in functional images.
Article in Computers in biology and medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Enhancing PET/CT Radiomics Robustness Through Graph Signal Processing.Diagnostics (Basel, Switzerland) · 2026Article
- Nutritional factors and survival in a cohort of patients with oral cancer.Frontiers in nutrition · 2025Article
- Enhancing Radiotherapy Workflow for Head and Neck Cancer with Artificial Intelligence: A Systematic Review.Journal of personalized medicine · 2023Review
- Proton boron capture therapy (PBCT) induces cell death and mitophagy in a heterotopic glioblastoma model.Communications biology · 2023Article
- matRadiomics: A Novel and Complete Radiomics Framework, from Image Visualization to Predictive Model.Journal of imaging · 2022Article
- Feasibility on the Use of Radiomics Features of 11[C]-MET PET/CT in Central Nervous System Tumours: Preliminary Results on Potential Grading Discrimination Using a Machine Learning Model.Current oncology (Toronto, Ont.) · 2021Article
- Changes of [BMC medical imaging · 2021Article
- Radiomics and machine learning applications in rectal cancer: Current update and future perspectives.World journal of gastroenterology · 2021Review
- Customized Efficient Neural Network for COVID-19 Infected Region Identification in CT Images.Journal of imaging · 2021Article
- Radiomics analysis of 18F-Choline PET/CT in the prediction of disease outcome in high-risk prostate cancer: an explorative study on machine learning feature classification in 94 patients.European radiology · 2021Article
- Automatic Segmentation of Mandible from Conventional Methods to Deep Learning-A Review.Journal of personalized medicine · 2021Review
- Artificial intelligence in molecular imaging.Annals of translational medicine · 2021Review
- Artificial intelligence for molecular neuroimaging.Annals of translational medicine · 2021Review
- Deep learning approach for the segmentation of aneurysmal ascending aorta.Biomedical engineering letters · 2021Article
- Reproducibility of Baseline Tumour Metabolic Volume Measurements in Diffuse Large B-Cell LymphomA: Is There a Superior Method?Metabolites · 2021Article
- Deep Learning-Based Methods for Prostate Segmentation in Magnetic Resonance Imaging.Applied sciences (Basel, Switzerland) · 2021Article
- Lung Segmentation on High-Resolution Computerized Tomography Images Using Deep Learning: A Preliminary Step for Radiomics Studies.Journal of imaging · 2020Article
- Fully 3D Active Surface with Machine Learning for PET Image Segmentation.Journal of imaging · 2020Article
- A preliminary PET radiomics study of brain metastases using a fully automatic segmentation method.BMC bioinformatics · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Delineation of tumours in Positron Emission Tomography (PET) plays a crucial role in accurate diagnosis and radiotherapy treatment planning. In this context, it is of outmost importance to devise efficient and operator-independent segmentation algorithms capable of reconstructing the tumour three-dimensional (3D) shape. In previous work, we proposed a system for 3D tumour delineation on PET data (expressed in terms of Standardized Uptake Value - SUV), based on a two-step approach. Step 1 identified the slice enclosing the maximum SUV and generated a rough contour surrounding it. Such contour was then used to initialize step 2, where the 3D shape of the tumour was obtained by separately segmenting 2D PET slices, leveraging the slice-by-slice marching approach. Additionally, we combined active contours and machine learning components to improve performance. Despite its success, the slice marching approach poses unnecessary limitations that are naturally removed by performing the segmentation directly in 3D. In this paper, we migrate our system into 3D. In particular, the segmentation in step 2 is now performed by evolving an active surface directly in the 3D space. The key points of such an advancement are that it performs the shape reconstruction on the whole stack of slices simultaneously, naturally leveraging cross-slice information that could not be exploited before. Additionally, it does not require any specific stopping condition, as the active surface naturally reaches a stable topology once convergence is achieved. Performance of this fully 3D approach is evaluated on the same dataset discussed in our previous work, which comprises fifty PET scans of lung, head and neck, and brain tumours. The results have confirmed that a benefit is indeed achieved in practice for all investigated anatomical districts, both quantitatively, through a set of commonly used quality indicators (dice similarity coefficient >87.66%, Hausdorff distance < 1.48 voxel and Mahalanobis distance < 0.82 voxel), and qualitatively in terms of Likert score (>3 in 54% of the tumours).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.